Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
protein degradation
Biotech
Nurix trims staff as trial for lead BTK degrader kicks off
The company declined to disclose how many employees were affected by the workforce reduction but added that no programs have been cut or paused.
Darren Incorvaia
Nov 21, 2025 5:05am
AbbVie-partnered protein degrader specialist Plexium raises $60M
Aug 28, 2025 12:52pm
Plexium cuts staff, realigns resources to support pipeline
Jun 3, 2025 4:12pm
Sanofi pays $15M for another STAT6 degrader from Nurix collab
Jun 2, 2025 9:50am
Big Pharma-backed GlycoEra raises $130M for protein degraders
May 27, 2025 7:00am
Revised Blueprint-VantAI deal turns focus to molecular glues
May 20, 2025 10:32am
